{"id":"W4387003753","doi":"10.1016/s2152-2650(23)01908-0","title":"P-290 Updated long-term follow-up results of a phase 1b/2 study (FUMANBA-1) in patients with relapsed/refractory multiple myeloma (RRMM) treated with equecabtagene autoleucel","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saskatchewan Cancer Agency; Memorial University of Newfoundland; University of Ottawa; McGill University; Princess Margaret Cancer Centre; Vancouver General Hospital; Micropharma (Canada); Nova Scotia Health Authority; Alberta Health Services; BC Cancer Agency; McMaster University; London Health Sciences Centre; Western University","funders":"","keywords":"Refractory (planetary science); Medicine; Term (time); Multiple myeloma; Phase (matter); Oncology; Internal medicine; Materials science; Physics; Metallurgy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002023776,0.0005089602,0.001208611,0.0005939911,0.0004694712,0.001492704,0.0007251788,0.0008291517,0.003318558],"category_scores_gemma":[0.002373655,0.0002894985,0.001381533,0.0008790273,0.0002102691,0.0008251026,0.0004207332,0.001216859,0.0007354778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000747614,"about_ca_system_score_gemma":0.0007325532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003105988,"about_ca_topic_score_gemma":0.005698756,"domain_scores_codex":[0.9993259,0.0002512698,0.00006959605,0.0001027716,0.0001700189,0.00008058621],"domain_scores_gemma":[0.9978063,0.0005408457,0.0006646261,0.0001742641,0.000512207,0.0003017936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2145931,0.003649203,0.4271375,0.002250004,0.01645143,0.001196778,0.000264035,0.00353567,0.02550474,0.0003185559,0.04432464,0.2607744],"study_design_scores_gemma":[0.03598231,0.02638838,0.8906153,0.0002091271,0.01238139,0.001343707,0.0001198959,0.00152173,0.005168904,0.0003787738,0.02582508,0.00006527286],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9066501,0.02220408,0.001912846,0.002385715,0.0005393563,0.0007634973,0.05580052,0.000335573,0.009408402],"genre_scores_gemma":[0.9461226,0.003157041,0.001624018,0.001486367,0.0002579339,0.0004701309,0.04298304,0.00006209345,0.003836681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003318558,"threshold_uncertainty_score":0.01110166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04524721464682365,"score_gpt":0.3501033137978773,"score_spread":0.3048560991510537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}